Key points are not available for this paper at this time.
Glaucoma is the leading cause of irreversible blindness with over 70 million people affected worldwide. The surgical management of glaucoma aims to lower intraocular pressure by increasing aqueous outflow facility. The latest manufacturing techniques have allowed for the development of a number of novel implantable devices to improve safety and outcomes of glaucoma surgery. These are collectively referred to as minimally invasive glaucoma surgery (MIGS) devices and are among the smallest devices implanted in the human body. This review discusses the design criterion and constraints as well as the user requirements for MIGS devices. We review how recent devices have attempted to meet these challenges and give our opinion as to the necessary characteristics for the development of future devices.
Building similarity graph...
Analyzing shared references across papers
Loading...
Richard M. H. Lee
Yann Bouremel
I. Eames
Clinical and Translational Science
University College London
Moorfields Eye Hospital NHS Foundation Trust
The London College
Building similarity graph...
Analyzing shared references across papers
Loading...
Lee et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6a04c2e0e6d1def091ad39d9 — DOI: https://doi.org/10.1111/cts.12660